1. Home
  2. NLOP vs QTRX Comparison

NLOP vs QTRX Comparison

Compare NLOP & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NLOP

Net Lease Office Properties of Beneficial Interest

HOLD

Current Price

$11.26

Market Cap

176.7M

Sector

N/A

ML Signal

HOLD

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.50

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NLOP
QTRX
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
176.7M
160.0M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
NLOP
QTRX
Price
$11.26
$3.50
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
110.2K
1.1M
Earning Date
05-19-2026
05-06-2026
Dividend Yield
52.20%
N/A
EPS Growth
N/A
N/A
EPS
1.69
N/A
Revenue
$118,915,000.00
$37,632,000.00
Revenue This Year
N/A
$25.49
Revenue Next Year
N/A
$10.04
P/E Ratio
$6.78
N/A
Revenue Growth
N/A
64.52
52 Week Low
$11.24
$2.40
52 Week High
$34.53
$8.77

Technical Indicators

Market Signals
Indicator
NLOP
QTRX
Relative Strength Index (RSI) 32.08 56.95
Support Level N/A $3.11
Resistance Level $12.26 $3.81
Average True Range (ATR) 0.30 0.35
MACD -0.02 0.04
Stochastic Oscillator 12.23 53.75

Price Performance

Historical Comparison
NLOP
QTRX

About NLOP Net Lease Office Properties of Beneficial Interest

Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Share on Social Networks: